荃信生物-B(02509)11月11日耗资约99.88万港元回购5.22万股
Qyuns TherapeuticsQyuns Therapeutics(HK:02509) 智通财经网·2025-11-11 13:38

Group 1 - The company, Zhenxin Biotechnology-B (02509), announced a share buyback on November 11, 2025, costing approximately HKD 998,800 for 52,200 shares [1]